BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15698678)

  • 21. Diagnostic specificity and neuroanatomical validity of neurological abnormalities in first-episode psychoses.
    Keshavan MS; Sanders RD; Sweeney JA; Diwadkar VA; Goldstein G; Pettegrew JW; Schooler NR
    Am J Psychiatry; 2003 Jul; 160(7):1298-304. PubMed ID: 12832245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stability in schizophrenia symptoms over time: findings from the Mount Sinai Pilgrim Psychiatric Center Longitudinal Study.
    Reichenberg A; Rieckmann N; Harvey PD
    J Abnorm Psychol; 2005 Aug; 114(3):363-72. PubMed ID: 16117573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mismatch negativity deficits are associated with poor functioning in schizophrenia patients.
    Light GA; Braff DL
    Arch Gen Psychiatry; 2005 Feb; 62(2):127-36. PubMed ID: 15699289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormal neurological signs, visual contrast sensitivity, and the deficit syndrome of schizophrenia.
    Cimmer C; Szendi I; Csifcsák G; Szekeres G; Ambrus Kovács Z; Somogyi I; Benedek G; Janka Z; Kéri S
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1225-30. PubMed ID: 16644085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional co-primary measures for clinical trials in schizophrenia: results from the MATRICS Psychometric and Standardization Study.
    Green MF; Nuechterlein KH; Kern RS; Baade LE; Fenton WS; Gold JM; Keefe RS; Mesholam-Gately R; Seidman LJ; Stover E; Marder SR
    Am J Psychiatry; 2008 Feb; 165(2):221-8. PubMed ID: 18172017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive functions in the involuntary hospitalized schizophrenic patients.
    Janović S; Bajs M
    Psychiatr Danub; 2005 Jun; 17(1-2):30-5. PubMed ID: 16395841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurocognitive deterioration in elderly chronic schizophrenia patients with and without PTSD.
    Goodman C; Finkel B; Naser M; Andreyev P; Segev Y; Kurs R; Melamed Y; Bleich A
    J Nerv Ment Dis; 2007 May; 195(5):415-20. PubMed ID: 17502807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of thought disorders on quality of life in patients with schizophrenia.
    Ulas H; Akdede BB; Ozbay D; Alptekin K
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):332-5. PubMed ID: 17854967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuropsychological symptom dimensions in bipolar disorder and schizophrenia.
    Czobor P; Jaeger J; Berns SM; Gonzalez C; Loftus S
    Bipolar Disord; 2007; 9(1-2):71-92. PubMed ID: 17391352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delineating psychomotor slowing from reduced processing speed in schizophrenia.
    Morrens M; Hulstijn W; Matton C; Madani Y; van Bouwel L; Peuskens J; Sabbe BG
    Cogn Neuropsychiatry; 2008 Nov; 13(6):457-71. PubMed ID: 19048439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurological signs and the heterogeneity of schizophrenia.
    Arango C; Kirkpatrick B; Buchanan RW
    Am J Psychiatry; 2000 Apr; 157(4):560-5. PubMed ID: 10739414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defining a cognitive function decrement in schizophrenia.
    Keefe RS; Eesley CE; Poe MP
    Biol Psychiatry; 2005 Mar; 57(6):688-91. PubMed ID: 15780858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Motoric neurological soft signs and psychopathological symptoms in schizophrenic psychoses.
    Jahn T; Hubmann W; Karr M; Mohr F; Schlenker R; Heidenreich T; Cohen R; Schröder J
    Psychiatry Res; 2006 Jun; 142(2-3):191-9. PubMed ID: 16650902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of neurological soft signs in schizophrenia: factor analysis of the Neurological Evaluation Scale.
    Sewell RA; Perry EB; Karper LP; Bell MD; Lysaker P; Goulet JL; Brenner L; Erdos J; d'Souza DC; Seibyl JP; Krystal JH
    Schizophr Res; 2010 Dec; 124(1-3):1-12. PubMed ID: 20855185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abnormal subjective experiences of schizophrenia: evaluation of the Eppendorf Schizophrenia Inventory.
    Mass R; Haasen C; Borgart EJ
    Psychiatry Res; 2005 Jun; 135(2):91-101. PubMed ID: 15913786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 12-Month stability of neurological soft signs in stabilized patients with schizophrenia.
    Fountoulakis KN; Panagiotidis P; Kimiskidis V; Nimatoudis I
    Nord J Psychiatry; 2019 Oct; 73(7):451-461. PubMed ID: 31393751
    [No Abstract]   [Full Text] [Related]  

  • 37. Cognitive performance and basic symptoms in first-degree relatives of schizophrenic patients.
    Bove EA
    Compr Psychiatry; 2008; 49(4):321-9. PubMed ID: 18555050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No, it is not possible to be schizophrenic yet neuropsychologically normal.
    Wilk CM; Gold JM; McMahon RP; Humber K; Iannone VN; Buchanan RW
    Neuropsychology; 2005 Nov; 19(6):778-86. PubMed ID: 16351353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formal thought disorder, neuropsychology and insight in schizophrenia.
    Barrera A; McKenna PJ; Berrios GE
    Psychopathology; 2009; 42(4):264-9. PubMed ID: 19521143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aggressive behavior model in schizophrenic patients.
    Song H; Min SK
    Psychiatry Res; 2009 May; 167(1-2):58-65. PubMed ID: 19359046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.